Published News

The Transition Towards Single-use Bioreactors

Roots Analysis has announced the addition of the “Single-use Bioreactors, 2014-2024” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of single-use bioreactors in the coming decade. In addition to the market forecasts, the report clearly identifies the various challenges and opportunities in the short and long term. It provides a comprehensive analysis of the market including profiles of ten established and emerging companies. Mayank Kaura, the lead analyst, said, “Single-use bioreactors are already being deployed for high density cell culture applications (monoclonal antibodies, recombinant proteins, vaccines etc.). Newer application areas being researched include stem cells and personalised medicine.” “We identified 17 manufacturers offering around 80-90 models of single-use bioreactors with working volumes ranging from as low as few millilitres to up to 2000L. Quite recently, many start-ups have sprung up. Examples include CerCell, PBS Biotech, Cellexus Limited; these start-ups have launched single-use bioreactors with innovative features and are likely to play an increasingly important role in the future.”


绗鍗佸叚绔 缃楁煆路鍙插斿厠锛堜笅锛 鎸栫熆妯℃嫙缁忚惀鍏嶈垂鎵嬫父銆奡toneMiner銆嬪缓璁句釜鎬у皬闀 鏀惰幏锛屽湪甯屾湜鐨勭敯閲庝笂鈥斺€斿啓鍦2021骞翠腑鍥藉啘姘戜赴鏀惰妭 绗涓冨崄浜旂珷 宸ㄩ瓟琛€缁 故事简介: 勇者乃‘超生物’!? 与魔王打成两败俱伤而彻底失去勇者之力的前勇者,少年布雷德。 照理来说,他应该如愿以偿地变成一名普通的学生了,可是他就读的学校竟是培育勇者的精英学校!? 在那裡上学的学生们当然都很优秀。 嘉阳出版社最近也开了新系列,是【嘉阳非常青春小说】,貌似包涵爱情元素。

มังกรฟ้า ลอตเตอรี่

แหล่งรวมลอตเตอรี่ ที่ใหญ่ที่สุดในไทย เราคือมังกรฟ้า สำนักงานใหญ่ ให้บริการ Platform การจัดระบบการซื้อ-ขายลอตเตอรี่บนออนไลน์ หรือหวยมังกรฟ้านั้น เพื่ออำนวยความสะดวกให้แก่ผู้ที่มีโควต้าล็อตเตอรี่ และให้เกิดตัวเลือกในการขายมากขึ้น

Antibody Drug Conjugates: Contract manufacturing market to evolve rapidly, predicts Roots Analysis

Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market, 2014-2024” report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this emerging class of therapeutics. It identifies various CMOs active in this space, their capabilities with respect to ADCs, available capacity (clinical/commercial) for bio-conjugation and geographic location/spread of the facilities. Shivani Singh, the principal analyst, said, “The multi-component aspect of ADCs deems it necessary to have both biologic and high-potency facilities. Despite the fact that this new class of therapeutic agents is gaining increased attention, in-house manufacturing of these molecules is rare.” “Most of the companies have limited number of ADCs under development. Considering that utilisation rates are likely to be low in near future, the investment required for setting up in-house high-containment biologic facilities is a huge financial risk. As such, majority of the work is currently being outsourced.”

خدمات عمل حر أعمال حرة مهني وكالات واستشارات خدمات عمل حر تسويق الكتروني العمل عن بعد تنتشر الخدمات والشركات المهنية المستقلة في كل مكان تقريبًا. ومع ذلك ، فإن أفضل طريقة للعثور على محترف